AHPBA Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma
January 21, 2010
The Peabody Orlando
9801 International Drive
Orlando, Florida
General Information
- Conference Brochure (pdf)
- Conference Agenda
- Committee and Speaker Information
- Registration Information
- Hotel & Transportation Information
- Orlando Visitor Information
Goal
The goal of the conference is to address knowledge gaps in the areas surrounding the preparation of patients with hepatocellular carcinoma (HCC) for surgery, optimal methods to control hepatocellular carcinoma while awaiting liver transplantation, and developing a multidisciplinary approach to these patients with the implementation of novel systemic therapies. This one-day event will be divided into three sessions with talks presented by experts in the field based on best level of evidence available from the literature. Each speaker will be asked to conclude his or her talk with a consensus statement (one slide). The panelists will be asked to review the appropriateness of these statements. The speakers will be asked to send their slide presentations to the panelists 6-8 weeks before the meeting to allow them to prepare for the discussion. For each talk presented, the speakers will be asked to submit a 600-900 word summary 6-8 weeks before their presentation. This will be incorporated into three manuscripts (one for each session) which will be reviewed by the designated panel. The proceedings of the meeting will be published after peer review in a major journal.
Educational Objectives
After attending the conference, participants should be able to
- Identify and risk stratify surgical candidates with hepatocellular carcinoma;
- Describe the optimal ways to bridge patients with hepatocellular carcinoma to transplant;
- Describe the ideal multidisciplinary environment in which to manage these patients;
- Identify systemic therapy options, as well as new and emerging technologies available to these patients.
Target Audience
This conference will be beneficial to surgical oncologists, medical oncologists, radiologists, interventional radiologists, hepatologists, gasteroenterologists, and transplant surgeons.
Educational Methods
- Lectures
- Question-and-Answer Sessions
- Panel Discussions
Evaluation
A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
Accreditation/Credit Designation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Texas M. D. Anderson Cancer Center and The American Hepato-Pancreato-Biliary Association. The University of Texas M. D. Anderson Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.
The University of Texas M. D. Anderson Cancer Center designates this educational activity for a maximum of 6.00 AMA PRA Category 1 Credits™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.